BriaCell Therapeutics Corp.
Disclosed SEC business address
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER, A1, V7T 2X1
BriaCell Therapeutics Corp. (ticker BCTXZ, CIK 0001610820) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Pharmaceutical Preparations (SIC 2834). Disclosed business address country: British Columbia, Canada. Every item is grounded on the cited public source — no figures are fabricated.
Go deeper
This is the free public preview. Open the deeper, source-linked evidence detail and the full in-app workspace. You have 4 free company deep views left this month.
Sources
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-10-31T06:56:17.828668+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-10-31T06:56:22.139608+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-10-31T06:56:25.938089+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-10-31T06:56:15.525175+00:00
Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.